Metadol-D (methadone hydrochloride)
Status:
Concluded with an LOI
Manufacturer:
Paladin Labs Inc.
Indication:
Opioid Dependence
Last updated December 19, 2016
Status:
Concluded with an LOI
Manufacturer:
ApoPharm Inc.
Indication:
Neutropenia in various indications (Prevention or treatment)
Last updated December 12, 2016
Status:
Concluded with an LOI
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Indication:
Chronic Idiopathic Urticaria
Last updated November 28, 2016
Orkambi (lumacaftor/ivacaftor)
Status:
Negotiations were not pursued
Manufacturer:
Vertex Pharmaceuticals (Canada) Incorporated
Indication:
Cystic Fibrosis, F508del CFTR mutation
Last updated November 22, 2016
Status:
Concluded with an LOI
Manufacturer:
Hospira Healthcare Corporation
Indication:
Ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, Crohn's disease and Ulcerative Colitis
Last updated October 31, 2016
Status:
Concluded with an LOI
Manufacturer:
Eli Lilly Canada Inc.
Indication:
Advanced or Metastatic Gastric Cancer or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Last updated October 27, 2016
Status:
Negotiations were not pursued
Manufacturer:
Janssen Inc.
Indication:
Metastatic Liposarcoma or Leiomyosarcoma
Last updated October 14, 2016
Status:
Negotiations were not pursued
Manufacturer:
Theratechnologies Inc.
Indication:
Lipodystrophy, HIV-infected patients
Last updated October 14, 2016
Status:
Concluded with an LOI
Manufacturer:
AstraZeneca Canada Inc.
Indication:
Diabetes Mellitus, Type 2
Last updated October 3, 2016
Status:
Concluded with an LOI
Manufacturer:
Shire Pharma Canada ULC
Indication:
Fabry Disease
Last updated October 1, 2016